Tremelimumab(anti-CTLA-4)
Tremelimumab(anti-CTLA-4)
CTLA-4 单抗;TREMELIMUMAB ( 曲美木单抗 );曲美木单抗;替西木单抗 CTLA-4 单抗;TREMELIMUMAB ( 曲美木单抗 );曲美木单抗;替西木单抗 展开
745013-59-6
C57H100N16O19S3Se
1488.6547088623
中文名称 Tremelimumab(anti-CTLA-4)
中文别名 CTLA-4 单抗;TREMELIMUMAB ( 曲美木单抗 );曲美木单抗;替西木单抗
英文名称 Tremelimumab(anti-CTLA-4)
英文别名 Ticilimumab;Tremelimumab;(2S,5S,8S,11R,14S,17S,20S,23S,26S,29S)-17-[(2S)-2-Butanyl]-29-[{[(2S)-5-carbamimidamido-1-hydroxy-1-;ticilimumab tremelimumab;Research Grade Tremelimumab (DHD17203);Research Grade Ticilimumab (DHD17204);Tremelimumab (anti-CTLA-4);Ticilimumab|||CP-675206
CAS No. 745013-59-6
分子式 C57H100N16O19S3Se
分子量 1488.66
象形图
警示语
Class
警告声明
UNub
危险声明
Packing Group
搜索质检报告(COA)
搜索MSDS